 | Up a level |
Boell, B., Buchheidt, D., Hasenkamp, J., Kiehl, M., Kiderlen, T., Kochanek, M., Koldehoff, M., Kostrewa, P., Loehnert, A., Mellinghoff, S. C., Metzner, B., Penack, O., Ruhnke, M., Enrico, S., Vehreschild, M., Weissinger, F., Wolf, H. -H, Hentrich, M. and Karthaus, M. (2018). New AGIHO-guideline for diagnosis and therapy of CVC-associated infections. Oncol. Res. Treat., 41. S. 147 - 148. BASEL: KARGER. ISSN 2296-5262
Fischer, R. N., Abdulla, D., Michels, S., Nogova, L., Brandes, V, Scheffler, M., Schaeffer, S., Scheel, A., Thurat, M., Vehreschild, M., Thomas, R., von Bergwelt-Baildon, M., Buettner, R. and Wolf, J. (2016). Bioluma: Biomarkers for nivolumab and evaluation of nivolumab plus ipilimumab in lung cancer - A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response to immune checkpoint inhibition. Oncol. Res. Treat., 39. S. 92 - 94. BASEL: KARGER. ISSN 2296-5262
Fischer, R. N., George, J., Schaefer, S., Scheel, A., Schloesser, H., Vehreschild, M., von Bergwelt-Baildon, M., Nogova, L., Abdulla, D. S. Y., Michels, S., Riedel, R., Scheffler, M., Brossart, P., Engel-Riedel, W., Griesinger, F., Grohe, C., Kambartel, K., Kern, J., Kopp, H-G, Neukirchen, J., Overbeck, T. R., Panse, J., Sebastian, M., Serke, M., Wiewrodt, R., Buettner, R., Thomas, R. and Wolf, J. (2018). BIOLUMA: Biomarkers for nivolumab and evaluation of nivolumab plus ipilimumab in lung cancer. Oncol. Res. Treat., 41. S. 270 - 272. BASEL: KARGER. ISSN 2296-5262
Heimann, S., Cornely, O., Wisplinghoff, H., Vehreschild, M., Franke, B. and Vehreschild, J. (2015). A Disease Cost Analysis of Clostridium difficile associated Diarrhea from the Perspective of the German Health System. Internist, 56. S. 57 - 59. NEW YORK: SPRINGER. ISSN 1432-1289
Heimann, S., Cornely, O., Wisplinghoff, H., Vehreschild, M., Franke, B. and Vehreschild, J. (2015). A Disease Cost Analysis of Clostridium difficile associated Diarrhea from the Perspective of the German Health System. Internist, 56. S. 57 - 59. NEW YORK: SPRINGER. ISSN 1432-1289
Heimann, S., Cornely, O. A., Meintker, L., Heinz, W., Schroeder, T., Vehreschild, M., Wisplinghoff, H., von Bergwelt-Baildon, M. and Vehreschild, J. (2014). Different Doses of Micafungin for Prophylaxis of Invasive Fungal Diseases: A Web-based Non-Interventional Trial in Four Large University Hospitals in Germany. Oncol. Res. Treat., 37. S. 121 - 122. BASEL: KARGER. ISSN 2296-5262
Solbach, P., Woltemate, S., Chhatwal, P., Tacconelli, E., Buhl, M., Gerhard, M., Vehreschild, M., Jazmati, N., Rupp, J., Manns, M. P., Bachmann, O. and Suerbaum, S. (2018). BaiCD gene abundance is negatively correlated with Clostridium difficile infection. J. Crohns Colitis, 12. S. S558 - 1. OXFORD: OXFORD UNIV PRESS. ISSN 1876-4479
Steinbach, A., Bacher, P., Kniemeyer, O., Hamprecht, A., Assenmacher, M., Vehreschild, M., Vehreschild, J., Koehler, P., Brakhage, A., Scheffold, A. and Cornely, O. (2015). Detection of invasive Mycosis by means of Fungus-reactive CD4+T Cells. Internist, 56. S. 58 - 60. NEW YORK: SPRINGER. ISSN 1432-1289
Steinbach, A., Bacher, P., Kniemeyer, O., Hamprecht, A., Assenmacher, M., Vehreschild, M., Vehreschild, J., Koehler, P., Brakhage, A., Scheffold, A. and Cornely, O. (2015). Detection of invasive Mycosis by means of Fungus-reactive CD4+T Cells. Internist, 56. S. 58 - 60. NEW YORK: SPRINGER. ISSN 1432-1289
Vehreschild, J., Heussel, C., Brecht, M., Vehreschild, M. and Cornely, O. (2015). Prediction of survival in Patients with Invasive Pulmonary Aspergillosis Using Volumetric Analysis of Computed Tomography Scans, Galactomannan and Absolute Neutrophil Count. Internist, 56. S. 57 - 58. NEW YORK: SPRINGER. ISSN 1432-1289
Vehreschild, J., Heussel, C., Brecht, M., Vehreschild, M. and Cornely, O. (2015). Prediction of survival in Patients with Invasive Pulmonary Aspergillosis Using Volumetric Analysis of Computed Tomography Scans, Galactomannan and Absolute Neutrophil Count. Internist, 56. S. 57 - 58. NEW YORK: SPRINGER. ISSN 1432-1289